Enhertu 100 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQR0N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,468
Award facts
- Contract value 100% obligated
- $37,468.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of 100 mg Enhertu vials, with a ceiling value of $37,468.20 and a firm fixed price structure. This non-set-aside contract is classified as a delivery order with an ultimate completion date of December 22, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Enhertu is a specialized pharmaceutical product used in oncology treatment, reflecting the Defense Logistics Agency's critical role in sourcing advanced medical therapeutics for military and veteran healthcare systems.
This delivery order is a child contract issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp has demonstrated substantial capacity to fulfill federal medical procurement requirements through competitive awards across multiple therapeutic domains and delivery modalities.
Quick answers
Who was awarded contract SPE2DR26FQR0N?
SPE2DR26FQR0N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FQR0N worth?
The government has obligated $37,468 on SPE2DR26FQR0N.
Is contract SPE2DR26FQR0N an order under another contract?
Yes. SPE2DR26FQR0N is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQR0N competed?
The extent of competition for SPE2DR26FQR0N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award